GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $41.00 $60.46 Thursday, 18th Apr 2024 BHVN stock ended at $42.16. This is 4.25% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 5.63% from a day low at $41.00 to a day high of $43.31.
90 days $41.00 $62.21
52 weeks $12.37 $62.21

Historical Biohaven Pharmaceutical Holding Company Ltd prices

Date Open High Low Close Volume
2024-04-18 $42.90 $43.31 $41.00 $42.16 3 607 532
2024-04-17 $44.14 $45.60 $42.55 $44.03 930 066
2024-04-16 $44.77 $45.07 $42.35 $43.77 1 917 088
2024-04-15 $50.96 $52.50 $43.58 $44.77 3 208 915
2024-04-12 $53.49 $53.70 $52.13 $53.08 774 543
2024-04-11 $51.53 $53.80 $51.20 $53.49 675 149
2024-04-10 $50.37 $51.60 $49.77 $51.06 708 374
2024-04-09 $51.62 $53.13 $50.85 $51.98 650 826
2024-04-08 $52.29 $52.33 $50.02 $51.41 756 088
2024-04-05 $51.93 $53.73 $51.36 $52.52 574 891
2024-04-04 $52.70 $55.69 $51.60 $52.33 879 258
2024-04-03 $50.25 $52.73 $50.25 $52.28 771 860
2024-04-02 $50.99 $52.15 $50.10 $50.79 953 828
2024-04-01 $54.69 $54.69 $51.60 $52.06 935 873
2024-03-28 $57.02 $57.02 $54.65 $54.69 821 546
2024-03-27 $56.88 $57.07 $54.22 $57.02 812 001
2024-03-26 $58.20 $59.53 $56.20 $56.29 1 347 102
2024-03-25 $55.62 $56.32 $55.20 $55.23 1 128 668
2024-03-22 $55.63 $56.43 $55.25 $55.85 529 153
2024-03-21 $60.17 $60.46 $55.85 $55.88 2 087 267
2024-03-20 $56.02 $59.37 $55.43 $59.36 900 790
2024-03-19 $56.01 $57.77 $55.61 $56.95 445 854
2024-03-18 $58.26 $58.97 $56.30 $56.74 1 852 345
2024-03-15 $55.32 $57.92 $54.95 $57.07 1 033 970
2024-03-14 $58.98 $59.15 $55.44 $56.42 1 982 361
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT